Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/ml1001085 http://scihub22266oqcxt.onion/10.1021/ml1001085 24900218/?report=reader!4007840!24900218     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ACS+Med+Chem+Lett 2010 ; 1 (7): 350-4 Nephropedia Template TP {{tp|p=24900218|t=2010. Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1 |pdf=|usr=}}{{24900218}} gab.com Text Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1 JO: ACS Med Chem Lett http://www.kidney.de/pget.php?&tw=1&pmid=24900218 #FOAvip Amalgamation of the structure-activity relationship of two series of GlyT1 inhibitors developed at Merck led to the discovery of a clinical candidate, compound 16 (DCCCyB), which demonstrated excellent in vivo occupancy of GlyT1 transporters in rhesus monkey as determined by displacement of a PET tracer ligand. Twit Text FOAVip Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1 ????ACS Med Chem Lett http://www.kidney.de/pget.php?&tw=1&pmid=24900218 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24900218 #FOAvip English Wikipedia <ref>{{Cite pmid|24900218}}</ref> Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1 #MMPMID24900218 Blackaby WP; Lewis RT; Thomson JL; Jennings AS; Goodacre SC; Street LJ; MacLeod AM; Pike A; Wood S; Thomas S; Brown TA; Smith A; Pillai G; Almond S; Guscott MR; Burns HD; Eng W; Ryan C; Cook J; Hamill TG ACS Med Chem Lett 2010[Oct]; 1 (7): 350-4 PMID24900218show ga Amalgamation of the structure-activity relationship of two series of GlyT1 inhibitors developed at Merck led to the discovery of a clinical candidate, compound 16 (DCCCyB), which demonstrated excellent in vivo occupancy of GlyT1 transporters in rhesus monkey as determined by displacement of a PET tracer ligand. äIdentification of an Orally Bioavailable, Potent, and Selective Inhibi(epmc).pdf DeepDyve Pubget Overpricing